Paul E. Aldrich

1.8k total citations · 1 hit paper
29 papers, 1.2k citations indexed

About

Paul E. Aldrich is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Paul E. Aldrich has authored 29 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 8 papers in Molecular Biology and 7 papers in Infectious Diseases. Recurrent topics in Paul E. Aldrich's work include HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (6 papers) and Chemical synthesis and alkaloids (4 papers). Paul E. Aldrich is often cited by papers focused on HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (6 papers) and Chemical synthesis and alkaloids (4 papers). Paul E. Aldrich collaborates with scholars based in United States, Australia and United Kingdom. Paul E. Aldrich's co-authors include Andrew T. Chiu, A.L. Johnson, Joseph B. Santella, John V. Duncia, William A. Price, David J. Carini, Gregory J. Wells, Michael E. Pierce, Eugene E. Van Tamelen and C. Nicholas Hodge and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Biochemical and Biophysical Research Communications.

In The Last Decade

Paul E. Aldrich

28 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives

1991 369 citations David J. Carini, John V. Duncia et al. Journal of Medicinal Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul E. Aldrich United States	16	532	497	240	206	135	29	1.2k
James R. Tata United States	21	606 1.1×	637 1.3×	87 0.4×	46 0.2×	46 0.3×	62	1.7k
Rajani Giridhar India	26	782 1.5×	542 1.1×	88 0.4×	45 0.2×	34 0.3×	97	1.6k
Steve R. Turner United States	12	528 1.0×	336 0.7×	189 0.8×	140 0.7×	36 0.3×	14	891
Bradley D. Tait United States	16	788 1.5×	480 1.0×	86 0.4×	53 0.3×	13 0.1×	27	1.5k
C. John Blankley United States	17	510 1.0×	419 0.8×	29 0.1×	15 0.1×	114 0.8×	33	1.0k
Andreas Blum Germany	14	506 1.0×	281 0.6×	49 0.2×	33 0.2×	35 0.3×	29	1.0k
Brian Springthorpe United Kingdom	5	546 1.0×	879 1.8×	89 0.4×	29 0.1×	30 0.2×	8	1.8k
Yoshiyasu Furukawa Japan	12	366 0.7×	374 0.8×	57 0.2×	13 0.1×	80 0.6×	35	707
Nicolas Kolocouris Greece	20	756 1.4×	443 0.9×	67 0.3×	19 0.1×	25 0.2×	49	1.3k
Isabella Fiorini Italy	21	568 1.1×	433 0.9×	121 0.5×	81 0.4×	12 0.1×	41	950

Countries citing papers authored by Paul E. Aldrich

Since Specialization

Citations

This map shows the geographic impact of Paul E. Aldrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul E. Aldrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul E. Aldrich more than expected).

Fields of papers citing papers by Paul E. Aldrich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul E. Aldrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul E. Aldrich. The network helps show where Paul E. Aldrich may publish in the future.

Co-authorship network of co-authors of Paul E. Aldrich

This figure shows the co-authorship network connecting the top 25 collaborators of Paul E. Aldrich. A scholar is included among the top collaborators of Paul E. Aldrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul E. Aldrich. Paul E. Aldrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Norberg, Melissa M., et al.. (2023). Situational, emotional, and individual dispositions to weight gain in people with hoarding problems. British Journal of Clinical Psychology. 62(2). 501–517.

Norberg, Melissa M., Susanne Meares, Richard J. Stevenson, et al.. (2023). Attention, response inhibition, and hoarding: A neuropsychological examination. Journal of Behavioral Addictions. 12(3). 827–839. 3 indexed citations

Hodge, C. Nicholas, Paul E. Aldrich, Zelda R. Wasserman, et al.. (1999). Corticotropin-Releasing Hormone Receptor Antagonists: Framework Design and Synthesis Guided by Ligand Conformational Studies. Journal of Medicinal Chemistry. 42(5). 819–832. 60 indexed citations

Hodge, C. Nicholas, Patrick Y. S. Lam, Charles J. Eyermann, et al.. (1998). Calculated and Experimental Low-Energy Conformations of Cyclic Urea HIV Protease Inhibitors. Journal of the American Chemical Society. 120(19). 4570–4581. 42 indexed citations

Lucca, George V. De, Jing Liang, Paul E. Aldrich, et al.. (1997). Design, Synthesis, and Evaluation of Tetrahydropyrimidinones as an Example of a General Approach to Nonpeptide HIV Protease Inhibitors. Journal of Medicinal Chemistry. 40(11). 1707–1719. 40 indexed citations

Rayner, Marlene M., et al.. (1994). DMP 323, a nonpeptide cyclic urea inhibitor of human immunodeficiency virus (HIV) protease, specifically and persistently blocks intracellular processing of HIV gag polyprotein. Antimicrobial Agents and Chemotherapy. 38(7). 1635–1640. 15 indexed citations

Hodge, C. Nicholas, et al.. (1994). Studies on Orally Available Inhibitors of HIV Protease. Peptidyl Aldehydes and Trifluoromethyl Ketones. Antiviral chemistry & chemotherapy. 5(4). 257–262. 8 indexed citations

Wong, Pancras C., Paul E. Aldrich, Andrew T. Chiu, et al.. (1993). Pharmacology of 2-amino-1,4-dihydro-4-(2-[4-[4-(2-methoxyphenyl)-1- piperazinyl]butylsulfinyl]phenyl)-6-methyl-5-nitro-3-pyridine carboxylic acid methyl ester (XB513), a novel calcium agonist with alpha-1 adrenergic receptor antagonistic.. Journal of Pharmacology and Experimental Therapeutics. 265(3). 1088–1095. 2 indexed citations

Garber, Sena, Dean L. Winslow, Carol Reid, et al.. (1993). In vitro isolation and identification of human immunodeficiency virus (HIV) variants with reduced sensitivity to C-2 symmetrical inhibitors of HIV type 1 protease.. Proceedings of the National Academy of Sciences. 90(16). 7543–7547. 114 indexed citations

10.

Carini, David J., John V. Duncia, Paul E. Aldrich, et al.. (1991). ChemInform Abstract: Nonpeptide Angiotensin II Receptor Antagonists: The Discovery of a Series of N‐(Biphenylylmethyl)imidazoles as Potent, Orally Active Antihypertensives.. ChemInform. 22(52). 1 indexed citations

11.

Carini, David J., John V. Duncia, Paul E. Aldrich, et al.. (1991). Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives. Journal of Medicinal Chemistry. 34(8). 2525–2547. 369 indexed citations breakdown →

12.

Chiu, Andrew T., Dale E. McCall, Paul E. Aldrich, & Pieter B.M.W.M. Timmermans. (1990). [3H]DuP 753, a highly potent and specific radioligand for the angiotensin II-1 receptor subtype. Biochemical and Biophysical Research Communications. 172(3). 1195–1202. 66 indexed citations

13.

Mullins, Laurie J. & Paul E. Aldrich. (1988). An Integrated Model of Management and Managerial Development. Journal of Management Development. 7(3). 29–39. 7 indexed citations

14.

Aldrich, Paul E., et al.. (1971). Antiviral agents. 2. Structure-activity relations of compounds related to 1-adamantanamine. Journal of Medicinal Chemistry. 14(6). 535–543. 75 indexed citations

15.

Aldrich, Paul E., Edward G. Howard, William J. Linn, William J. Middleton, & W. H. Sharkey. (1963). Secondary and Tertiary Perfluoroörganomercury Compounds. The Journal of Organic Chemistry. 28(1). 184–188. 29 indexed citations

16.

Aldrich, Paul E., Charles F. Huebner, H. B. MacPhillamy, et al.. (1959). The Stereochemistry of Reserpine, Deserpidine and Related Alkaloids^1,2. Journal of the American Chemical Society. 81(10). 2481–2494. 16 indexed citations

17.

Aldrich, Paul E., et al.. (1957). Stereochemistry of Corynantheine, Dihydrocorynantheine and Corynantheidine¹. Journal of the American Chemical Society. 79(24). 6426–6430. 13 indexed citations

18.

Tamelen, Eugene E. Van, Paul E. Aldrich, & Jackson B. Hester. (1957). Stereochemistry of the Ipecac Alkaloids. Journal of the American Chemical Society. 79(17). 4817–4818. 8 indexed citations

19.

Tamelen, Eugene E. Van, Maurice Shamma, & Paul E. Aldrich. (1956). The Stereospecific Synthesis of dl-Yohimbane. Stereochemistry of Yohimbine¹. Journal of the American Chemical Society. 78(18). 4628–4632. 16 indexed citations

20.

Wolf, Donald E., Carl H. Hoffman, Paul E. Aldrich, et al.. (1956). β-HYDROXY-β-METHYL-δ-VALEROLACTONE (DIVALONIC ACID), A NEW BIOLOGICAL FACTOR. Journal of the American Chemical Society. 78(17). 4499–4499. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact